Grant: CANADA-HOPE Scholarship Program / Fellowship
McMaster University
$56,000.00
Vascular events In noncardiac Surgery patIents' cOhort evaluatioN study (VISION): Vascular Surgery Substudy and NT-proBNP Bio-bank Study
FY 2009-10
Summary
Worldwide there are more than 200 million adults have major surgery every year, and millions of these patients will suffer a major vascular complication (i.e., death, heart attack, cardiac arrest, or stroke) in the first 30 days after their surgery. Despite the magnitude of this problem, there are no known effective and safe interventions to accurately monitor, prevent or manage these events.
VISION is the world's largest international prospective perioperative cohort study including patients 45 years of age or older whom are undergoing noncardiac surgery that requires hospital admission.
The VISION Vascular Surgery Substudy will include approximately 5000 vascular surgery patients. The primary objectives of the VISION Vascular Surgery substudy are to determine the: 1) incidence of major vascular events at 30 days after surgery, 2) the optimal clinical model to predict major vascular events at 30 days after surgery; 3) proportion of patients 30 days after surgery with perioperative myocardial infarctions that may go undetected without troponin monitoring; and 4) relationship between postoperative troponin measurements and the 1 year risk of vascular death.
Secondly the VISION NT-proBNP Bio-bank Study will examine the prognostic capabilities of NT-proBNP in the postoperative period to predict cardiovascular events. A recent small study has suggested that a postoperative elevation in the biomarker released from the heart called brain natriuretic peptide (BNP) is able to identify patients who will experience major vascular complications.
Department
Program
CANADA-HOPE Scholarship Program / Fellowship
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
206271
Name
Rodseth Reitze N
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Aventis Pharma
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Canada-HOPE Scholarships
Projecttitle
Vascular events In noncardiac Surgery patIents' cOhort evaluatioN study (VISION): Vascular Surgery Substudy and NT-proBNP Bio-bank Study
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$56,000
Cihrequipment2
$0
Programname2
CANADA-HOPE Scholarship Program / Fellowship
Keyworddelim
Bio-Bank; Biomarkers; Perioperative Cardiovascular Medicine; Randomized Controlled Trial; Vascular Events; Vascular Surgery
Abstract
Worldwide there are more than 200 million adults have major surgery every year, and millions of these patients will suffer a major vascular complication (i.e., death, heart attack, cardiac arrest, or stroke) in the first 30 days after their surgery. Despite the magnitude of this problem, there are no known effective and safe interventions to accurately monitor, prevent or manage these events.
VISION is the world's largest international prospective perioperative cohort study including patients 45 years of age or older whom are undergoing noncardiac surgery that requires hospital admission.
The VISION Vascular Surgery Substudy will include approximately 5000 vascular surgery patients. The primary objectives of the VISION Vascular Surgery substudy are to determine the: 1) incidence of major vascular events at 30 days after surgery, 2) the optimal clinical model to predict major vascular events at 30 days after surgery; 3) proportion of patients 30 days after surgery with perioperative myocardial infarctions that may go undetected without troponin monitoring; and 4) relationship between postoperative troponin measurements and the 1 year risk of vascular death.
Secondly the VISION NT-proBNP Bio-bank Study will examine the prognostic capabilities of NT-proBNP in the postoperative period to predict cardiovascular events. A recent small study has suggested that a postoperative elevation in the biomarker released from the heart called brain natriuretic peptide (BNP) is able to identify patients who will experience major vascular complications.
Competitiondate
201003
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Rodseth, Reitze N
Approvedterm
2 ans 0 mois
Cihrcontribution2
Pan - Institute init. (MISI)~ $56,000~ $0~